DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 189 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $636,540 | -10.5% | 41,200 | -5.1% | 0.00% | 0.0% |
| Q4 2022 | $711,326 | -17.1% | 43,400 | -10.9% | 0.00% | 0.0% |
| Q3 2022 | $858,000 | +540.3% | 48,700 | +377.5% | 0.00% | – |
| Q2 2022 | $134,000 | -73.2% | 10,200 | -30.6% | 0.00% | -100.0% |
| Q3 2021 | $500,000 | +11.6% | 14,707 | 0.0% | 0.00% | – |
| Q2 2021 | $448,000 | -60.0% | 14,707 | -41.1% | 0.00% | -100.0% |
| Q1 2021 | $1,120,000 | -10.5% | 24,982 | +14.0% | 0.00% | -50.0% |
| Q4 2020 | $1,251,000 | +11.3% | 21,919 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,124,000 | -41.8% | 21,919 | -32.2% | 0.00% | -33.3% |
| Q2 2020 | $1,930,000 | +57.7% | 32,319 | +8.7% | 0.00% | +50.0% |
| Q1 2020 | $1,224,000 | -38.6% | 29,719 | -7.2% | 0.00% | -33.3% |
| Q4 2019 | $1,993,000 | +443.1% | 32,019 | +196.0% | 0.00% | +200.0% |
| Q3 2019 | $367,000 | – | 10,819 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $11,213,000 | 5.53% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,580,456 | $51,731,000 | 1.16% |
| ARMISTICE CAPITAL, LLC | 5,836,000 | $54,100,000 | 1.05% |
| Pinz Capital Management, LP | 165,835 | $1,537,000 | 0.96% |
| Sunesis Advisors, LLC | 96,299 | $893,000 | 0.52% |
| Redmile Group, LLC | 664,817 | $6,163,000 | 0.19% |
| PDT Partners, LLC | 222,343 | $2,061,000 | 0.18% |
| Bayesian Capital Management, LP | 41,900 | $388,000 | 0.06% |
| Laurion Capital Management LP | 459,290 | $4,258,000 | 0.05% |
| Hennion & Walsh Asset Management, Inc. | 101,643 | $942,000 | 0.05% |